SCHEMBL17592804

SCHEMBL17592804

CC1(CCCc2ccccc2)C(=O)OCOC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
GAA P10253 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NAAA Q02083 5/20 0.38
HDAC3 O15379 1/20 0.37
MAPK1 P28482 1/20 0.37
ADRA1A P35348 1/20 0.37
HDAC4 P56524 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17468379 0.81 ELANE (0.41) MAOAMAOBNAAAADRA1ASLC6A3
SCHEMBL17592809 0.80 CYP3A4 (0.34)
SCHEMBL17593127 0.80 ELANE (0.50) MAOAMAOBGAAL3MBTL1SMN1; SMN2
SCHEMBL22728644 0.77 GAA (0.38) GAAL3MBTL1NAAAHDAC3MAPK1
SCHEMBL11742230 0.74 L3MBTL1 (0.41) GAAL3MBTL1
SCHEMBL16736246 0.73 HSD17B10 (0.38)
SCHEMBL22728634 0.72 HTR7 (0.41) NAAAADRA1ASLC6A3
SCHEMBL22914872 0.70 GAA (0.43) GAAL3MBTL1
SCHEMBL6380088 0.70 MAOA (0.42) MAOAMAOBL3MBTL1SMN1; SMN2GSK3B
SCHEMBL17550624 0.68 RAB9A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786199-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2021-03-03 EP claimed
EP-3191533-B1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS INC (US) 2020-11-04 EP claimed
US-10308802-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof SIRRUS, INC. (US) 2019-06-04 US claimed
US-20170275446-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF NIPPON SHOKUBAI CO., LTD. (JP) 2017-09-28 US claimed
EP-3191533-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2017-07-19 EP claimed
WO-2016040261-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS, INC. (US) 2016-03-17 WO claimed
US-11021617-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof SIRRUS, INC. (US) 2021-06-01 US disclosed
EP-3786199-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2021-03-03 EP disclosed
EP-3191533-B1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS INC (US) 2020-11-04 EP disclosed
US-10703842-B2 Encapsulated polymerization initiators, polymerization systems and methods using the same SIRRUS, INC. (US) 2020-07-07 US disclosed
US-20200190369-A1 1,1 DISUBSTITUTED ALKENE COMPOUND BASED PRESSURE SENSITIVE ADHESIVES SIRRUS, INC. 2020-06-18 US disclosed
US-20190263955-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS, INC. 2019-08-29 US disclosed
US-10308802-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof SIRRUS, INC. (US) 2019-06-04 US disclosed
US-20170247490-A1 ENCAPSULATED POLYMERIZATION INITIATORS, POLYMERIZATION SYSTEMS AND METHODS USING THE SAME SIRRUS, INC. 2017-08-31 US disclosed
EP-3191533-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF Sirrus, Inc. (US) 2017-07-19 EP disclosed
US-9683147-B2 Encapsulated polymerization initiators, polymerization systems and methods using the same SIRRUS, INC. (US) 2017-06-20 US disclosed
WO-2016195817-A1 ENCAPSULATED POLYMERIZATION INITIATORS, POLYMERIZATION SYSTEMS AND METHODS USING THE SAME SIRRUS, INC. (US) 2016-12-08 WO disclosed
US-20160347976-A1 ENCAPSULATED POLYMERIZATION INITIATORS, POLYMERIZATION SYSTEMS AND METHODS USING THE SAME SIRRUS, INC. 2016-12-01 US disclosed
US-9334430-B1 Encapsulated polymerization initiators, polymerization systems and methods using the same SIRRUS, INC. (US) 2016-05-10 US disclosed
WO-2016040261-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF SIRRUS, INC. (US) 2016-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263955-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF PCBP1, PARG, PARP1 MAOA 2532/4885MAOB 3053/4885GAA 1306/4885
US-10308802-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof PCBP1, PARG, PARP1 MAOA 2654/4885MAOB 3091/4885GAA 1196/4885
US-20170275446-A1 POLYMERS INCLUDING ONE OR MORE 1,1-DISUBSTITUTED ALKENE COMPOUNDS AND POLYMER COMPOSITIONS THEREOF PCBP1, PARG, PARP1 MAOA 2654/4885MAOB 3091/4885GAA 1196/4885
US-11021617-B2 Polymers including one or more 1,1-disubstituted alkene compounds and polymer compositions thereof PCBP1, PARG, PARP1 MAOA 2532/4885MAOB 3053/4885GAA 1306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.